May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
Prevalence of Posterior Ophthalmic Disease in Patients Seen in a Collaborative Infectious Disease/Ophthalmology Clinic Setting
Author Affiliations & Notes
  • D.A. Gill
    Ophthalmology, Mount Sinai Medical Center, New York, NY
    Ophthalmology, Elmhurst Hospital Center, Queens, NY
  • R.M. Lieberman
    Ophthalmology, Mount Sinai Medical Center, New York, NY
    Ophthalmology, Elmhurst Hospital Center, Queens, NY
  • B. Rubin
    SUNY at Stony Brook Medical Center, Stony Brook, NY
  • R.M. Fischer
    Ophthalmology, Mount Sinai Medical Center, New York, NY
    Ophthalmology, Elmhurst Hospital Center, Queens, NY
  • Footnotes
    Commercial Relationships  D.A. Gill, None; R.M. Lieberman, None; B. Rubin, None; R.M. Fischer, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 1013. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      D.A. Gill, R.M. Lieberman, B. Rubin, R.M. Fischer; Prevalence of Posterior Ophthalmic Disease in Patients Seen in a Collaborative Infectious Disease/Ophthalmology Clinic Setting . Invest. Ophthalmol. Vis. Sci. 2005;46(13):1013.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To ascertain the prevalence of posterior ophthalmic disease in HIV positive patients seen in a city hospital over a two year period. Methods: The charts of the patients seen in the I.D./EYE clinic from 11/02–11/04 were reviewed for the diagnosis of either infectious posterior ophthalmic disease, or a CNS lesion that would result in visual dysfunction. Patients with both inactive and newly diagnosed disease were included. In addition, specific infectious etiologies were identified. Results: The total number of patients seen was 420. Of these patients, 107 (26%) were found to have posterior ophthalmic disease. The infectious etiologies were as follows: cytomegalovirus retinitis (CMVR) active 6 (5.6%), CMVR inactive 15 (14%), chorioretinitis (CR) 2o syphilis 8 (7.5%), CR 2o TB 5 (4.7%), CR 2o pneumocystis carini 1(0.09%), toxoplasmosis gondii 6 (5.6 %), optic atrophy 2° cryptococcal meningitis 2 (1.9%) and HIV microangiopathy 69 (65%). Of the subset with posterior ophthalmic disease, 3 (2.8%) had two infectious diagnoses. Conclusions: The prevalence and distribution of types of posterior ophthalmic disease in these patients differs markedly from those in the pre–HAART era. Practitioners need to be aware of these changing demographics in order to provide superior ophthalmic care to all HIV positive patients.

Keywords: AIDS/HIV • clinical (human) or epidemiologic studies: prevalence/incidence • chorioretinitis 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×